# Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic

> **NCT04437719** · NA · COMPLETED · sponsor: **Fondation Hôpital Saint-Joseph** · enrollment: 34 (actual)

## Conditions studied

- Oncology
- COVID-19

## Interventions

- **OTHER:** Obvio-19 app

## Key facts

- **NCT ID:** NCT04437719
- **Lead sponsor:** Fondation Hôpital Saint-Joseph
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-29
- **Primary completion:** 2021-06-28
- **Final completion:** 2022-06-03
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2022-06-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04437719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04437719, "Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04437719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*